Yoshihiko Fujita Selected Research

Yoshihiko Fujita Research Topics

Disease

41	Neoplasms (Cancer) 08/2023 - 06/2003
14	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2020 - 12/2008
7	Colorectal Neoplasms (Colorectal Cancer) 01/2019 - 03/2010
6	Pain (Aches) 08/2023 - 12/2011
5	Cancer Pain 08/2023 - 01/2017
5	Lung Neoplasms (Lung Cancer) 04/2015 - 11/2012
4	Stomach Neoplasms (Stomach Cancer) 08/2015 - 03/2009
3	Adenocarcinoma 01/2021 - 12/2011
3	Pancreatic Neoplasms (Pancreatic Cancer) 06/2017 - 05/2014
3	Melanoma (Melanoma, Malignant) 06/2016 - 01/2013
3	Hepatocellular Carcinoma (Hepatoma) 01/2016 - 01/2011
3	Lymphoma (Lymphomas) 03/2015 - 05/2012
3	Hemorrhage 01/2015 - 01/2013
2	Breast Neoplasms (Breast Cancer) 01/2022 - 10/2012
2	Carcinoma (Carcinomatosis) 10/2017 - 12/2011
2	Peptic Ulcer (Peptic Ulcers) 01/2015 - 12/2014
2	Ulcer 01/2015 - 12/2014
2	Hypoxia (Hypoxemia) 10/2014 - 12/2007
1	Margins of Excision 01/2022
1	Fibromyalgia (Fibrositis) 03/2017
1	Inflammation (Inflammations) 03/2017
1	Infections 03/2017
1	Diabetes Mellitus 03/2017
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 11/2016
1	Glioblastoma (Glioblastoma Multiforme) 06/2016
1	Barrett Esophagus (Barrett's Esophagus) 01/2016
1	Squamous Cell Carcinoma of Head and Neck 01/2016
1	Cachexia 01/2015
1	Adenocarcinoma of Lung 01/2015
1	Cardiovascular Diseases (Cardiovascular Disease) 12/2014

Drug/Important Bio-Agent (IBA)

11	Biomarkers (Surrogate Marker)IBA 08/2023 - 03/2011
9	Tyrosine Kinase InhibitorsIBA 08/2016 - 12/2008
8	Opioid Analgesics (Opioids)IBA 08/2023 - 12/2011
8	ErbB Receptors (EGF Receptor)IBA 08/2016 - 12/2008
7	Morphine (MS Contin)FDA LinkGeneric 08/2023 - 12/2011
6	Proteins (Proteins, Gene)FDA Link 08/2014 - 12/2007
6	Messenger RNA (mRNA)IBA 01/2014 - 03/2009
4	Catechol O-Methyltransferase (Methyltransferase, Catechol)IBA 01/2023 - 05/2012
4	Erlotinib Hydrochloride (CP 358,774)FDA Link 06/2017 - 09/2013
4	Phosphotransferases (Kinase)IBA 12/2016 - 05/2012
3	Oxycodone (Oxycontin)FDA LinkGeneric 08/2023 - 10/2017
3	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 12/2016 - 12/2014
3	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 03/2015 - 05/2012
3	DNA (Deoxyribonucleic Acid)IBA 01/2015 - 11/2012
3	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2015 - 01/2013
3	Gefitinib (Iressa)FDA Link 09/2013 - 08/2008
2	LigandsIBA 08/2023 - 01/2019
2	Acetaminophen (Paracetamol)FDA LinkGeneric 01/2023 - 10/2017
2	AfatinibIBA 12/2020 - 01/2016
2	Paclitaxel (Taxol)FDA LinkGeneric 01/2019 - 04/2013
2	nintedanibIBA 11/2016 - 03/2011
2	TRO-A0001IBA 06/2016 - 01/2013
2	Rotaxanes (Rotaxane)IBA 06/2016 - 01/2013
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2016 - 08/2015
2	trametinibIBA 08/2015 - 12/2014
2	CrizotinibIBA 03/2015 - 10/2014
2	Activins (Activin)IBA 01/2015 - 05/2014
2	CateninsIBA 01/2015 - 02/2012
2	Formaldehyde (Formol)FDA Link 01/2015 - 01/2015
2	ParaffinIBA 01/2015 - 01/2015
2	Cadherins (E-Cadherin)IBA 10/2014 - 02/2012
2	Transcription Factors (Transcription Factor)IBA 04/2013 - 12/2007
2	Erythropoietin FDA Link 12/2007 - 06/2003
1	Histamine N-MethyltransferaseIBA 08/2023
1	Analgesics (Analgesic Drugs)IBA 08/2023
1	ChemokinesIBA 08/2023
1	Immune Checkpoint InhibitorsIBA 01/2019
1	Bevacizumab (Avastin)FDA Link 01/2019
1	Irinotecan (Camptosar)FDA LinkGeneric 01/2019
1	Immune Checkpoint ProteinsIBA 01/2019
1	Carboplatin (JM8)FDA LinkGeneric 01/2019
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2019
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 10/2017
1	Diphosphonates (Bisphosphonates)IBA 10/2017
1	Hemoglobins (Hemoglobin)IBA 03/2017
1	C-Reactive ProteinIBA 03/2017
1	Carnitine (L-Carnitine)FDA LinkGeneric 03/2017
1	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 01/2017
1	tyrosine receptor (receptor, tyrosine)IBA 12/2016
1	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 11/2016
1	Cetuximab (Erbitux)FDA Link 01/2016
1	CollagenIBA 01/2016
1	Indicators and Reagents (Reagents)IBA 01/2016
1	Zonula Occludens-1 ProteinIBA 01/2016
1	Nicotine FDA Link 04/2015
1	alectinibIBA 03/2015
1	Cyclooxygenase 1IBA 01/2015
1	Cytotoxins (Cytolysins)IBA 01/2015
1	AntibodiesIBA 01/2015
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2015
1	Type 1 Angiotensin ReceptorIBA 01/2015
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2015
1	ProstaglandinsIBA 01/2015

Therapy/Procedure

10	Therapeutics 08/2023 - 06/2003
6	Drug Therapy (Chemotherapy) 01/2022 - 12/2008
2	Radiotherapy 01/2022 - 10/2017
2	Aftercare (After-Treatment) 08/2015 - 03/2015
1	Palliative Care (Palliative Therapy) 01/2023
1	Mammaplasty (Breast Reconstruction) 01/2022
1	Immunotherapy 01/2019